qfx

It is here that our tale takes a turn-like a crooked street in a town where logic has fled and only absurdity rules. Rivermont, with the precision of a blind clockmaker, divested itself of a prodigious share of its holdings-shrinking from an assertive 8.9% of its portfolio’s pride to a mere 1.9%, as if the entire enterprise was an overgrown garden, suddenly pruned by an invisible but capricious gardener. The stock, once a giant within their chest of assets, now lay modestly at 1.9%-a diminutive figure that would cause even the most hardened broker to pinch themselves or perhaps, more appropriately, to marvel at the relentless march of valuation, which had seen SXT’s share price ascend to $96.11-a number that gleamed brighter than the fullest moon, up 32% over the span of a weary year-outstripping the sluggish S&P whose sluggish pulse rose a mere 15%.

Not a gym routine, but potentially just as painful.

Absolute Gestao de Investimentos, a name that suggests order yet whispers of chaos, revealed a third-quarter stake in Chart Industries (GTLS 0.04%). The position, worth $88.22 million as of September 30, was disclosed in a filing that arrived like an uninvited guest. The fund, which reported $769.14 million in U.S. assets, now holds 35 equity positions-each a thread in a tapestry of global macro themes.

These funds let you play with Bitcoin and Ether like they’re Monopoly money, but don’t let the “high-risk tolerance” line fool you. If you’re not prepared to lose sleep over a 30% drop, maybe stick to investing in your Netflix subscription. After all, at least that won’t make you want to scream into a pillow.

The transaction, detailed in the SEC filing, reflects a strategic adjustment. Stonepine’s exposure to Indivior now constitutes 1.96% of its reportable assets under management, down from 5.06% in the prior quarter. This shift aligns with broader portfolio reallocations, as the fund maintains significant positions in other biotech firms.